<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">35693009</PMID><DateRevised><Year>2023</Year><Month>09</Month><Day>16</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1664-2295</ISSN><JournalIssue CitedMedium="Print"><Volume>13</Volume><PubDate><Year>2022</Year></PubDate></JournalIssue><Title>Frontiers in neurology</Title><ISOAbbreviation>Front Neurol</ISOAbbreviation></Journal><ArticleTitle>Molecular Mechanisms of Neuroinflammation in ME/CFS and Long COVID to Sustain Disease and Promote Relapses.</ArticleTitle><Pagination><StartPage>877772</StartPage><MedlinePgn>877772</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">877772</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fneur.2022.877772</ELocationID><Abstract><AbstractText>Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) is a disease now well-documented as having arisen commonly from a viral infection, but also from other external stressors, like exposure to agricultural chemicals, other types of infection, surgery, or other severe stress events. Research has shown these events produce a systemic molecular inflammatory response and chronic immune activation and dysregulation. What has been more difficult to establish is the hierarchy of the physiological responses that give rise to the myriad of symptoms that ME/CFS patients experience, and why they do not resolve and are generally life-long. The severity of the symptoms frequently fluctuates through relapse recovery periods, with brain-centered symptoms of neuroinflammation, loss of homeostatic control, "brain fog" affecting cognitive ability, lack of refreshing sleep, and poor response to even small stresses. How these brain effects develop with ME/CFS from the initiating external effector, whether virus or other cause, is poorly understood and that is what our paper aims to address. We propose the hypothesis that following the initial stressor event, the subsequent systemic pathology moves to the brain <i>via</i> neurovascular pathways or through a dysfunctional blood-brain barrier (BBB), resulting in chronic neuroinflammation and leading to a sustained illness with chronic relapse recovery cycles. Signaling through recognized pathways from the brain back to body physiology is likely part of the process by which the illness cycle in the peripheral system is sustained and why healing does not occur. By contrast, Long COVID (Post-COVID-19 condition) is a very recent ME/CFS-like illness arising from the single pandemic virus, SARS-CoV-2. We believe the ME/CFS-like ongoing effects of Long COVID are arising by very similar mechanisms involving neuroinflammation, but likely with some unique signaling, resulting from the pathology of the initial SARS-CoV-2 infection. The fact that there are very similar symptoms in both ongoing diseases, despite the diversity in the nature of the initial stressors, supports the concept of a similar dysfunctional CNS component common to both.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 Tate, Walker, Sweetman, Helliwell, Peppercorn, Edgar, Blair and Chatterjee.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tate</LastName><ForeName>Warren</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Biochemistry, University of Otago, Dunedin, New Zealand.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Brain Health Research Centre, University of Otago, Dunedin, New Zealand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Walker</LastName><ForeName>Max</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Biochemistry, University of Otago, Dunedin, New Zealand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sweetman</LastName><ForeName>Eiren</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Biochemistry, University of Otago, Dunedin, New Zealand.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Biological Sciences, Victoria University of Wellington, Wellington, New Zealand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Helliwell</LastName><ForeName>Amber</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Biochemistry, University of Otago, Dunedin, New Zealand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peppercorn</LastName><ForeName>Katie</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Biochemistry, University of Otago, Dunedin, New Zealand.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Brain Health Research Centre, University of Otago, Dunedin, New Zealand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Edgar</LastName><ForeName>Christina</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Biochemistry, University of Otago, Dunedin, New Zealand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Blair</LastName><ForeName>Anna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Graduate School of Health, University of Technology Sydney, Sydney, NSW, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chatterjee</LastName><ForeName>Aniruddha</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Pathology, University of Otago, Dunedin, New Zealand.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>05</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Neurol</MedlineTA><NlmUniqueID>101546899</NlmUniqueID><ISSNLinking>1664-2295</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">ME/CFS</Keyword><Keyword MajorTopicYN="N">disease persistence</Keyword><Keyword MajorTopicYN="N">neuroinflammation</Keyword><Keyword MajorTopicYN="N">relapse</Keyword><Keyword MajorTopicYN="N">systemic inflammation</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>2</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>4</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>6</Month><Day>13</Day><Hour>3</Hour><Minute>9</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>6</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>6</Month><Day>14</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>5</Month><Day>25</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35693009</ArticleId><ArticleId IdType="pmc">PMC9174654</ArticleId><ArticleId IdType="doi">10.3389/fneur.2022.877772</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Gilliam AG. Epidemiological study of an epidemic, diagnosed as poliomyelitis, occurring among the personnel of the los angeles county general hospital during the summer of 1934. Public Health Bull. (1938) 130:231&#x2013;40.</Citation></Reference><Reference><Citation>Sigurdsson B. Clinical findings six years after outbreak of Akureyri disease. Lancet. (1956) 270:766&#x2013;7. 10.1016/S0140-6736(56)91236-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(56)91236-3</ArticleId><ArticleId IdType="pubmed">13320872</ArticleId></ArticleIdList></Reference><Reference><Citation>Staff M. AN OUTBREAK of encephalomyelitis in the Royal Free Hospital Group, London, in 1955. Br Med J. (1957) 2:895&#x2013;904. 10.1136/bmj.2.5050.895</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.2.5050.895</ArticleId><ArticleId IdType="pmc">PMC1962472</ArticleId><ArticleId IdType="pubmed">13472002</ArticleId></ArticleIdList></Reference><Reference><Citation>Levine PH, Jacobson S, Pocinki AG, Cheney P, Peterson D, Connelly RR, et al. . Clinical, epidemiologic, and virologic studies in four clusters of the chronic fatigue syndrome. Arch Intern Med. (1992) 152:1611&#x2013;6. 10.1001/archinte.152.8.1611</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archinte.152.8.1611</ArticleId><ArticleId IdType="pubmed">1323246</ArticleId></ArticleIdList></Reference><Reference><Citation>Levine PH, Snow PG, Ranum BA, Paul C, Holmes MJ. Epidemic neuromyasthenia and chronic fatigue syndrome in west Otago, New Zealand. A 10-year follow-up. Arch Intern Med. (1997) 157:750&#x2013;4. 10.1001/archinte.157.7.750</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archinte.157.7.750</ArticleId><ArticleId IdType="pubmed">9125006</ArticleId></ArticleIdList></Reference><Reference><Citation>VanElzakker MB, Brumfield SA, Lara Mejia PS. Neuroinflammation and cytokines in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): a critical review of research methods. Front Neurol. (2018) 9:1033. 10.3389/fneur.2018.01033</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2018.01033</ArticleId><ArticleId IdType="pmc">PMC6335565</ArticleId><ArticleId IdType="pubmed">30687207</ArticleId></ArticleIdList></Reference><Reference><Citation>Sweetman E, Noble A, Edgar C, Mackay A, Helliwell A, Vallings R, et al. . Current research provides insight into the biological basis and diagnostic potential for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). Diagnostics. (2019) 9:73. 10.3390/diagnostics9030073</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/diagnostics9030073</ArticleId><ArticleId IdType="pmc">PMC6787691</ArticleId><ArticleId IdType="pubmed">31295930</ArticleId></ArticleIdList></Reference><Reference><Citation>Fukuda K, Straus SE, Hickie I, Sharpe MC, Dobbins JG, Komaroff A. The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group. Ann Intern Med. (1994) 121:953&#x2013;9. 10.7326/0003-4819-121-12-199412150-00009</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-121-12-199412150-00009</ArticleId><ArticleId IdType="pubmed">7978722</ArticleId></ArticleIdList></Reference><Reference><Citation>Carruthers BM, Jain AK, De Meirleir KL, Peterson DL, Klimas NG, Lerner AM, et al. . Myalgic encephalomyelitis/chronic fatigue syndrome. J Chron Fatigue Syndrome. (2003) 11:7&#x2013;115. 10.1300/J092v11n01_02</Citation><ArticleIdList><ArticleId IdType="doi">10.1300/J092v11n01_02</ArticleId></ArticleIdList></Reference><Reference><Citation>Carruthers BM, van de Sande MI, De Meirleir KL, Klimas NG, Broderick G, Mitchell T, et al. . Myalgic encephalomyelitis: international consensus criteria. J Intern Med. (2011) 270:327&#x2013;38. 10.1111/j.1365-2796.2011.02428.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2796.2011.02428.x</ArticleId><ArticleId IdType="pmc">PMC3427890</ArticleId><ArticleId IdType="pubmed">21777306</ArticleId></ArticleIdList></Reference><Reference><Citation>Komaroff AL, Lipkin WI. Insights from myalgic encephalomyelitis/chronic fatigue syndrome may help unravel the pathogenesis of postacute COVID-19 syndrome. Trends Mol Med. (2021) 27:895&#x2013;906. 10.1016/j.molmed.2021.06.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molmed.2021.06.002</ArticleId><ArticleId IdType="pmc">PMC8180841</ArticleId><ArticleId IdType="pubmed">34175230</ArticleId></ArticleIdList></Reference><Reference><Citation>Institute Institute of Medicine NAoS USA . Diagnostic Criteria for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. The National Academies Collection: Reports funded by National Institutes of Health. Washington, DC: National Academies Press (US).</Citation></Reference><Reference><Citation>Bateman L, Bested AC, Bonilla HF, Chheda BV, Chu L, Curtin JM, et al. . Myalgic encephalomyelitis/chronic fatigue syndrome: essentials of diagnosis and management. Mayo Clin Proc. (2021) 96:2861&#x2013;78. 10.1016/j.mayocp.2021.07.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mayocp.2021.07.004</ArticleId><ArticleId IdType="pubmed">34454716</ArticleId></ArticleIdList></Reference><Reference><Citation>Dong E, Du H, Gardner L. An interactive web-based dashboard to track COVID-19 in real time. Lancet Infect Dis. (2020) 20:533&#x2013;4. 10.1016/S1473-3099(20)30120-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(20)30120-1</ArticleId><ArticleId IdType="pmc">PMC7159018</ArticleId><ArticleId IdType="pubmed">32087114</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, Assaf GS, McCorkell L, Wei H, Low RJ, Re'em Y, et al. . Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine. (2021) 38:101019. 10.1016/j.eclinm.2021.101019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101019</ArticleId><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO. 
A clinical case definition of post COVID-19 condition by a Delphi consensus. WHO (2021). Available online at: https://www.who.int/publications/i/item/WHO-2019-nCoV-Post_COVID-19_condition-Clinical_case_definition-2021.1:WHOREFERENCENUMBER:~WHO/2019-nCoV/Post_COVID-19_condition/Clinical_case_definition/2021.1 (accessed February, 2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius R. Could microclots help explain the mystery of long Covid? The Guardian. (2022).</Citation></Reference><Reference><Citation>Sukocheva OA, Maksoud R, Beeraka NM, Madhunapantula SV, Sinelnikov M, Nikolenko VN, et al. . Analysis of post COVID-19 condition and its overlap with myalgic encephalomyelitis/chronic fatigue syndrome. J. Adv. Res. (2021) 1&#x2013;18. 10.1016/j.jare.2021.11.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jare.2021.11.013</ArticleId><ArticleId IdType="pmc">PMC8619886</ArticleId><ArticleId IdType="pubmed">36100326</ArticleId></ArticleIdList></Reference><Reference><Citation>Komaroff AL. Advances in Understanding the Pathophysiology of Chronic Fatigue Syndrome. JAMA. (2019) 322:499&#x2013;500. 10.1001/jama.2019.8312</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2019.8312</ArticleId><ArticleId IdType="pubmed">31276153</ArticleId></ArticleIdList></Reference><Reference><Citation>Felman A. Everything you need to know about inflammation: Medical News Today. (2020). Available online at: https://www.medicalnewstoday.com/articles/248423 (accessed February, 2022).</Citation></Reference><Reference><Citation>Harvard HP. 2020. Available from: https://www.health.harvard.edu/staying-healthy/understanding-acute-and-chronic-inflammation</Citation></Reference><Reference><Citation>Furman D, Campisi J, Verdin E, Carrera-Bastos P, Targ S, Franceschi C, et al. . Chronic inflammation in the etiology of disease across the life span. Nat Med. (2019) 25:1822&#x2013;32. 10.1038/s41591-019-0675-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-019-0675-0</ArticleId><ArticleId IdType="pmc">PMC7147972</ArticleId><ArticleId IdType="pubmed">31806905</ArticleId></ArticleIdList></Reference><Reference><Citation>DiSabato DJ, Quan N, Godbout JP. Neuroinflammation: the devil is in the details. J Neurochem. (2016) 139(Suppl 2.):136&#x2013;53. 10.1111/jnc.13607</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnc.13607</ArticleId><ArticleId IdType="pmc">PMC5025335</ArticleId><ArticleId IdType="pubmed">26990767</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohan C. Microglia in Acute and Chronic Inflammation. Temecula, CA: Science News; (2017). 10.5005/jp/books/12948_20</Citation><ArticleIdList><ArticleId IdType="doi">10.5005/jp/books/12948_20</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Y, Dissing-Olesen L, MacVicar BA, Stevens B. Microglia: dynamic mediators of synapse development and plasticity. Trends Immunol. (2015) 36:605&#x2013;13. 10.1016/j.it.2015.08.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.it.2015.08.008</ArticleId><ArticleId IdType="pmc">PMC4841266</ArticleId><ArticleId IdType="pubmed">26431938</ArticleId></ArticleIdList></Reference><Reference><Citation>Rogers J, Mastroeni D, Leonard B, Joyce J, Grover A. Neuroinflammation in Alzheimer's disease and Parkinson's disease: are microglia pathogenic in either disorder? Int Rev Neurobiol. (2007) 82:235&#x2013;46. 10.1016/S0074-7742(07)82012-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0074-7742(07)82012-5</ArticleId><ArticleId IdType="pubmed">17678964</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackay A, Tate WP. A compromised paraventricular nucleus within a dysfunctional hypothalamus: a novel neuroinflammatory paradigm for ME/CFS. Int J Immunopathol Pharmacol. (2018) 32:2058738418812342. 10.1177/2058738418812342</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/2058738418812342</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackay A. A paradigm for post-Covid-19 fatigue syndrome analogous to ME/CFS. Front Neurol. (2021) 12:701419. 10.3389/fneur.2021.701419</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2021.701419</ArticleId><ArticleId IdType="pmc">PMC8365156</ArticleId><ArticleId IdType="pubmed">34408721</ArticleId></ArticleIdList></Reference><Reference><Citation>Godoy LD, Rossignoli MT, Delfino-Pereira P, Garcia-Cairasco N, de Lima Umeoka EH. A comprehensive overview on stress neurobiology: basic concepts and clinical implications. Front Behav Neurosci. (2018) 12:127. 10.3389/fnbeh.2018.00127</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnbeh.2018.00127</ArticleId><ArticleId IdType="pmc">PMC6043787</ArticleId><ArticleId IdType="pubmed">30034327</ArticleId></ArticleIdList></Reference><Reference><Citation>Naviaux RK, Naviaux JC, Li K, Bright AT, Alaynick WA, Wang L, et al. . Metabolic features of chronic fatigue syndrome. Proc Natl Acad Sci USA. (2016) 113:E5472&#x2013;80. 10.1073/pnas.1607571113</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1607571113</ArticleId><ArticleId IdType="pmc">PMC5027464</ArticleId><ArticleId IdType="pubmed">27573827</ArticleId></ArticleIdList></Reference><Reference><Citation>Naviaux RK. Metabolic features and regulation of the healing cycle-A new model for chronic disease pathogenesis and treatment. Mitochondrion. (2019) 46:278&#x2013;97. 10.1016/j.mito.2018.08.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mito.2018.08.001</ArticleId><ArticleId IdType="pubmed">30099222</ArticleId></ArticleIdList></Reference><Reference><Citation>Sweetman E, Ryan M, Edgar C, MacKay A, Vallings R, Tate W. Changes in the transcriptome of circulating immune cells of a New Zealand cohort with myalgic encephalomyelitis/chronic fatigue syndrome. Int J Immunopathol Pharmacol. (2019) 33:2058738418820402. 10.1177/2058738418820402</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/2058738418820402</ArticleId><ArticleId IdType="pmc">PMC6350121</ArticleId><ArticleId IdType="pubmed">30791746</ArticleId></ArticleIdList></Reference><Reference><Citation>Sweetman E, Kleffmann T, Edgar C, de Lange M, Vallings R, Tate W. A SWATH-MS analysis of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome peripheral blood mononuclear cell proteomes reveals mitochondrial dysfunction. J Transl Med. (2020) 18:365. 10.1186/s12967-020-02533-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-020-02533-3</ArticleId><ArticleId IdType="pmc">PMC7512220</ArticleId><ArticleId IdType="pubmed">32972442</ArticleId></ArticleIdList></Reference><Reference><Citation>Helliwell AM, Sweetman EC, Stockwell PA, Edgar CD, Chatterjee A, Tate WP. Changes in DNA methylation profiles of myalgic encephalomyelitis/chronic fatigue syndrome patients reflect systemic dysfunctions. Clin Epigenet. (2020) 12:167. 10.1186/s13148-020-00960-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13148-020-00960-z</ArticleId><ArticleId IdType="pmc">PMC7641803</ArticleId><ArticleId IdType="pubmed">33148325</ArticleId></ArticleIdList></Reference><Reference><Citation>Ledderose C, Junger WG. Mitochondria synergize with P2 receptors to regulate human T cell function. Front Immunol. (2020) 11:549889. 10.3389/fimmu.2020.549889</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.549889</ArticleId><ArticleId IdType="pmc">PMC7550529</ArticleId><ArticleId IdType="pubmed">33133068</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferguson AV, Latchford KJ, Samson WK. The paraventricular nucleus of the hypothalamus - a potential target for integrative treatment of autonomic dysfunction. Expert Opin Ther Targets. (2008) 12:717&#x2013;27. 10.1517/14728222.12.6.717</Citation><ArticleIdList><ArticleId IdType="doi">10.1517/14728222.12.6.717</ArticleId><ArticleId IdType="pmc">PMC2682920</ArticleId><ArticleId IdType="pubmed">18479218</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y, Rao B, Li S, Zheng N, Wang J, Bi L, et al. . Distinct hypothalamic paraventricular nucleus inputs to the cingulate cortex and paraventricular thalamic nucleus modulate anxiety and arousal. Front Pharmacol. (2022) 13:814623. 10.3389/fphar.2022.814623</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2022.814623</ArticleId><ArticleId IdType="pmc">PMC8832877</ArticleId><ArticleId IdType="pubmed">35153786</ArticleId></ArticleIdList></Reference><Reference><Citation>Kempuraj D, Thangavel R, Selvakumar GP, Zaheer S, Ahmed ME, Raikwar SP, et al. . Brain and peripheral atypical inflammatory mediators potentiate neuroinflammation and neurodegeneration. Front Cell Neurosci. (2017) 11:216. 10.3389/fncel.2017.00216</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2017.00216</ArticleId><ArticleId IdType="pmc">PMC5522882</ArticleId><ArticleId IdType="pubmed">28790893</ArticleId></ArticleIdList></Reference><Reference><Citation>Takesue K, Kishi T, Hirooka Y, Sunagawa K. Activation of microglia within paraventricular nucleus of hypothalamus is NOT involved in maintenance of established hypertension. J Cardiol. (2017) 69:84&#x2013;8. 10.1016/j.jjcc.2016.01.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jjcc.2016.01.004</ArticleId><ArticleId IdType="pubmed">26874752</ArticleId></ArticleIdList></Reference><Reference><Citation>Hirooka Y, Kishi T, Ito K, Sunagawa K. Potential clinical application of recently discovered brain mechanisms involved in hypertension. Hypertension. (2013) 62:995&#x2013;1002. 10.1161/HYPERTENSIONAHA.113.00801</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/HYPERTENSIONAHA.113.00801</ArticleId><ArticleId IdType="pubmed">24101665</ArticleId></ArticleIdList></Reference><Reference><Citation>Calcia MA, Bonsall DR, Bloomfield PS, Selvaraj S, Barichello T, Howes OD. Stress and neuroinflammation: a systematic review of the effects of stress on microglia and the implications for mental illness. Psychopharmacology. (2016) 233:1637&#x2013;50. 10.1007/s00213-016-4218-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00213-016-4218-9</ArticleId><ArticleId IdType="pmc">PMC4828495</ArticleId><ArticleId IdType="pubmed">26847047</ArticleId></ArticleIdList></Reference><Reference><Citation>Hatziagelaki E, Adamaki M, Tsilioni I, Dimitriadis G, Theoharides TC. Myalgic encephalomyelitis/chronic fatigue syndrome-metabolic disease or disturbed homeostasis due to focal inflammation in the hypothalamus? J Pharmacol Exp Ther. (2018) 367:155&#x2013;67. 10.1124/jpet.118.250845</Citation><ArticleIdList><ArticleId IdType="doi">10.1124/jpet.118.250845</ArticleId><ArticleId IdType="pubmed">30076265</ArticleId></ArticleIdList></Reference><Reference><Citation>Brenu EW, van Driel ML, Staines DR, Ashton KJ, Ramos SB, Keane J, et al. . Immunological abnormalities as potential biomarkers in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis. J Transl Med. (2011) 9:81. 10.1186/1479-5876-9-81</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1479-5876-9-81</ArticleId><ArticleId IdType="pmc">PMC3120691</ArticleId><ArticleId IdType="pubmed">21619669</ArticleId></ArticleIdList></Reference><Reference><Citation>Montoya JG, Holmes TH, Anderson JN, Maecker HT, Rosenberg-Hasson Y, Valencia IJ, et al. . Cytokine signature associated with disease severity in chronic fatigue syndrome patients. Proc Natl Acad Sci USA. (2017) 114:E7150&#x2013;8. 10.1073/pnas.1710519114</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1710519114</ArticleId><ArticleId IdType="pmc">PMC5576836</ArticleId><ArticleId IdType="pubmed">28760971</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandarano AH, Maya J, Giloteaux L, Peterson DL, Maynard M, Gottschalk CG, et al. . Myalgic encephalomyelitis/chronic fatigue syndrome patients exhibit altered T cell metabolism and cytokine associations. J Clin Invest. (2020) 130:1491&#x2013;505. 10.1172/JCI132185</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI132185</ArticleId><ArticleId IdType="pmc">PMC7269566</ArticleId><ArticleId IdType="pubmed">31830003</ArticleId></ArticleIdList></Reference><Reference><Citation>Deumer US, Varesi A, Floris V, Savioli G, Mantovani E, Lopez-Carrasco P, et al. . Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): an overview. J Clin Med. (2021) 10:4786. 10.3390/jcm10204786</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10204786</ArticleId><ArticleId IdType="pmc">PMC8538807</ArticleId><ArticleId IdType="pubmed">34682909</ArticleId></ArticleIdList></Reference><Reference><Citation>Hornig M, Montoya JG, Klimas NG, Levine S, Felsenstein D, Bateman L, et al. . Distinct plasma immune signatures in ME/CFS are present early in the course of illness. Sci Adv. (2015) 1:e1400121. 10.1126/sciadv.1400121</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.1400121</ArticleId><ArticleId IdType="pmc">PMC4465185</ArticleId><ArticleId IdType="pubmed">26079000</ArticleId></ArticleIdList></Reference><Reference><Citation>Kellogg RA, Dunn J, Snyder MP. Personal omics for precision health. Circ Res. (2018) 122:1169&#x2013;71. 10.1161/CIRCRESAHA.117.310909</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.117.310909</ArticleId><ArticleId IdType="pubmed">29700064</ArticleId></ArticleIdList></Reference><Reference><Citation>Helliwell A, Tate WP. Dynamic epigenetic changes during a relapse and recovery cycle in myalgic encephalomyelitis/chronic fatigue syndrome. medRxiv. (2022) 1&#x2013;33. 10.1101/2022.02.24.22270912</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.02.24.22270912</ArticleId><ArticleId IdType="pmc">PMC9570248</ArticleId><ArticleId IdType="pubmed">36233152</ArticleId></ArticleIdList></Reference><Reference><Citation>Comas M, Gordon CJ, Oliver BG, Stow NW, King G, Sharma P, et al. . A circadian based inflammatory response &#x2013; implications for respiratory disease and treatment. Sleep Sci Pract. (2017) 1:18. 10.1186/s41606-017-0019-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s41606-017-0019-2</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu T, Zhang L, Joo D, Sun S-C. NF-&#x3ba;B signaling in inflammation. Signal Transd Targeted Ther. (2017) 2:17023. 10.1038/sigtrans.2017.23</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sigtrans.2017.23</ArticleId><ArticleId IdType="pmc">PMC5661633</ArticleId><ArticleId IdType="pubmed">29158945</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayden MS, Ghosh S. Regulation of NF-&#x3ba;B by TNF family cytokines. Semin Immunol. (2014) 26:253&#x2013;66. 10.1016/j.smim.2014.05.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.smim.2014.05.004</ArticleId><ArticleId IdType="pmc">PMC4156877</ArticleId><ArticleId IdType="pubmed">24958609</ArticleId></ArticleIdList></Reference><Reference><Citation>Hornig M, Gottschalk CG, Eddy ML, Che X, Ukaigwe JE, Peterson DL, et al. . Immune network analysis of cerebrospinal fluid in myalgic encephalomyelitis/chronic fatigue syndrome with atypical and classical presentations. Transl Psychiatry. (2017) 7:e1080. 10.1038/tp.2017.44</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/tp.2017.44</ArticleId><ArticleId IdType="pmc">PMC5416687</ArticleId><ArticleId IdType="pubmed">28375204</ArticleId></ArticleIdList></Reference><Reference><Citation>Blaser H, Dostert C, Mak TW, Brenner D. TNF and ROS Crosstalk in Inflammation. Trends Cell Biol. (2016) 26:249&#x2013;61. 10.1016/j.tcb.2015.12.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tcb.2015.12.002</ArticleId><ArticleId IdType="pubmed">26791157</ArticleId></ArticleIdList></Reference><Reference><Citation>Magnani F, Mattevi A. Structure and mechanisms of ROS generation by NADPH oxidases. Curr Opin Struct Biol. (2019) 59:91&#x2013;7. 10.1016/j.sbi.2019.03.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.sbi.2019.03.001</ArticleId><ArticleId IdType="pubmed">31051297</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng A, Hou Y, Mattson MP. Mitochondria and neuroplasticity. ASN Neuro. (2010) 2:e00045. 10.1042/AN20100019</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/AN20100019</ArticleId><ArticleId IdType="pmc">PMC2949087</ArticleId><ArticleId IdType="pubmed">20957078</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y, Zhou Z, Min W. Mitochondria, oxidative stress and innate immunity. Front Physiol. (2018) 9:1487. 10.3389/fphys.2018.01487</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2018.01487</ArticleId><ArticleId IdType="pmc">PMC6200916</ArticleId><ArticleId IdType="pubmed">30405440</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang S, Wang J, Brand DD, Zheng SG. Role of TNF-TNF receptor 2 signal in regulatory T cells and its therapeutic implications. Front Immunol. (2018) 9:784. 10.3389/fimmu.2018.00784</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.00784</ArticleId><ArticleId IdType="pmc">PMC5916970</ArticleId><ArticleId IdType="pubmed">29725328</ArticleId></ArticleIdList></Reference><Reference><Citation>Missailidis D, Annesley SJ, Allan CY, Sanislav O, Lidbury BA, Lewis DP, et al. . An isolated complex V Inefficiency and dysregulated mitochondrial function in immortalized lymphocytes from ME/CFS patients. Int J Mol Sci. (2020) 21:1074. 10.3390/ijms21031074</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21031074</ArticleId><ArticleId IdType="pmc">PMC7036826</ArticleId><ArticleId IdType="pubmed">32041178</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandez-Guerra P, Gonzalez-Ebsen AC, Boonen SE, Courraud J, Gregersen N, Mehlsen J, et al. . Bioenergetic and proteomic profiling of immune cells in myalgic encephalomyelitis/chronic fatigue syndrome patients: an exploratory study. Biomolecules. (2021) 11:961. 10.3390/biom11070961</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biom11070961</ArticleId><ArticleId IdType="pmc">PMC8301912</ArticleId><ArticleId IdType="pubmed">34209852</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilkins HM, Swerdlow RH. Relationships between mitochondria and neuroinflammation: implications for Alzheimer's disease. Curr Top Med Chem. (2016) 16:849&#x2013;57. 10.2174/1568026615666150827095102</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1568026615666150827095102</ArticleId><ArticleId IdType="pmc">PMC5480219</ArticleId><ArticleId IdType="pubmed">26311426</ArticleId></ArticleIdList></Reference><Reference><Citation>Lawson N, Hsieh CH, March D, Wang X. Elevated energy production in chronic fatigue syndrome patients. J Nat Sci. (2016) 2:e221. 10.1016/j.stem.2016.08.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stem.2016.08.002</ArticleId><ArticleId IdType="pmc">PMC5065105</ArticleId><ArticleId IdType="pubmed">27747291</ArticleId></ArticleIdList></Reference><Reference><Citation>Booth NE, Myhill S, McLaren-Howard J. Mitochondrial dysfunction and the pathophysiology of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS). Int J Clin Exp Med. (2012) 5:208&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3403556</ArticleId><ArticleId IdType="pubmed">22837795</ArticleId></ArticleIdList></Reference><Reference><Citation>Galluzzi L, Kepp O, Kroemer G. Mitochondria: master regulators of danger signalling. Nat Rev Mol Cell Biol. (2012) 13:780&#x2013;8. 10.1038/nrm3479</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrm3479</ArticleId><ArticleId IdType="pubmed">23175281</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilkins HM, Carl SM, Greenlief AC, Festoff BW, Swerdlow RH. Bioenergetic dysfunction and inflammation in Alzheimer's disease: a possible connection. Front Aging Neurosci. (2014) 6:311. 10.3389/fnagi.2014.00311</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2014.00311</ArticleId><ArticleId IdType="pmc">PMC4226164</ArticleId><ArticleId IdType="pubmed">25426068</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius E, Vlok M, Venter C, Bezuidenhout JA, Laubscher GJ, Steenkamp J, et al. . Persistent clotting protein pathology in Long COVID/Post-Acute Sequelae of COVID-19 (PASC) is accompanied by increased levels of antiplasmin. Cardiovasc Diabetol. (2021) 20:172. 10.1186/s12933-021-01359-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12933-021-01359-7</ArticleId><ArticleId IdType="pmc">PMC8381139</ArticleId><ArticleId IdType="pubmed">34425843</ArticleId></ArticleIdList></Reference><Reference><Citation>Chatterjee A, Stockwell PA, Rodger EJ, Morison IM. Comparison of alignment software for genome-wide bisulphite sequence data. Nucleic Acids Res. (2012) 40:e79. 10.1093/nar/gks150</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gks150</ArticleId><ArticleId IdType="pmc">PMC3378906</ArticleId><ArticleId IdType="pubmed">22344695</ArticleId></ArticleIdList></Reference><Reference><Citation>Chatterjee A, Rodger EJ, Morison IM, Eccles MR, Stockwell PA. Tools and strategies for analysis of genome-wide and gene-specific DNA methylation patterns. Methods Mol Biol. (2017) 1537:249&#x2013;77. 10.1007/978-1-4939-6685-1_15</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-4939-6685-1_15</ArticleId><ArticleId IdType="pubmed">27924599</ArticleId></ArticleIdList></Reference><Reference><Citation>Stockwell PA, Chatterjee A, Rodger EJ, Morison IM. DMAP: differential methylation analysis package for RRBS and WGBS data. Bioinformatics. (2014) 30:1814&#x2013;22. 10.1093/bioinformatics/btu126</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btu126</ArticleId><ArticleId IdType="pubmed">24608764</ArticleId></ArticleIdList></Reference><Reference><Citation>Akalin A, Kormaksson M, Li S, Garrett-Bakelman FE, Figueroa ME, Melnick A, et al. . methylKit: a comprehensive R package for the analysis of genome-wide DNA methylation profiles. Genome Biol. (2012) 13:R87. 10.1186/gb-2012-13-10-r87</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/gb-2012-13-10-r87</ArticleId><ArticleId IdType="pmc">PMC3491415</ArticleId><ArticleId IdType="pubmed">23034086</ArticleId></ArticleIdList></Reference><Reference><Citation>Tomas C, Newton J, Watson S. A review of hypothalamic-pituitary-adrenal axis function in chronic fatigue syndrome. ISRN Neurosci. (2013) 2013:784520. 10.1155/2013/784520</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2013/784520</ArticleId><ArticleId IdType="pmc">PMC4045534</ArticleId><ArticleId IdType="pubmed">24959566</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackay A. A neuro-inflammatory model can explain the onset, symptoms and flare-ups of myalgic encephalomyelitis/chronic fatigue syndrome. J Prim Health Care. (2019) 11:300&#x2013;7. 10.1071/HC19041</Citation><ArticleIdList><ArticleId IdType="doi">10.1071/HC19041</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakatomi Y, Mizuno K, Ishii A, Wada Y, Tanaka M, Tazawa S, et al. . Neuroinflammation in patients with chronic fatigue syndrome/myalgic encephalomyelitis: an (1)(1)C-(R)-PK11195 PET study. J Nucl Med. (2014) 55:945&#x2013;50. 10.2967/jnumed.113.131045</Citation><ArticleIdList><ArticleId IdType="doi">10.2967/jnumed.113.131045</ArticleId><ArticleId IdType="pubmed">24665088</ArticleId></ArticleIdList></Reference><Reference><Citation>Raijmakers R, Roerink M, Keijmel S, Joosten L, Netea M, van der Meer J, et al. . No signs of neuroinflammation in women with chronic fatigue syndrome or Q fever fatigue syndrome using the TSPO ligand [(11)C]-PK11195. Neurol Neuroimmunol Neuroinflamm. (2022) 9:e1113. 10.1212/NXI.0000000000001113</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/NXI.0000000000001113</ArticleId><ArticleId IdType="pmc">PMC8611501</ArticleId><ArticleId IdType="pubmed">34815320</ArticleId></ArticleIdList></Reference><Reference><Citation>Nelson T, Zhang LX, Guo H, Nacul L, Song X. Brainstem abnormalities in myalgic encephalomyelitis/chronic fatigue syndrome: a scoping review and evaluation of magnetic resonance imaging findings. Front Neurol. (2021) 12:769511. 10.3389/fneur.2021.769511</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2021.769511</ArticleId><ArticleId IdType="pmc">PMC8718708</ArticleId><ArticleId IdType="pubmed">34975729</ArticleId></ArticleIdList></Reference><Reference><Citation>Barnden LR, Kwiatek R, Crouch B, Burnet R, Del Fante P. Autonomic correlations with MRI are abnormal in the brainstem vasomotor centre in Chronic Fatigue Syndrome. Neuroimage Clin. (2016) 11:530&#x2013;7. 10.1016/j.nicl.2016.03.017</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nicl.2016.03.017</ArticleId><ArticleId IdType="pmc">PMC4833047</ArticleId><ArticleId IdType="pubmed">27114901</ArticleId></ArticleIdList></Reference><Reference><Citation>Yong SJ. Persistent brainstem dysfunction in long-COVID: a hypothesis. ACS Chem Neurosci. (2021) 12:573&#x2013;80. 10.1021/acschemneuro.0c00793</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acschemneuro.0c00793</ArticleId><ArticleId IdType="pubmed">33538586</ArticleId></ArticleIdList></Reference><Reference><Citation>Mueller C, Lin JC, Sheriff S, Maudsley AA, Younger JW. Evidence of widespread metabolite abnormalities in Myalgic encephalomyelitis/chronic fatigue syndrome: assessment with whole-brain magnetic resonance spectroscopy. Brain Imaging Behav. (2020) 14:562&#x2013;72. 10.1007/s11682-018-0029-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11682-018-0029-4</ArticleId><ArticleId IdType="pmc">PMC6612467</ArticleId><ArticleId IdType="pubmed">30617782</ArticleId></ArticleIdList></Reference><Reference><Citation>Younger JW ME/CFS International Conference 2021: Research Innovation and Discovery Gold Coast FL (2021) .</Citation></Reference><Reference><Citation>Mathur D, Mishra BK, Rout S, Lopez-Iranzo FJ, Lopez-Rodas G, Vallamkondu J, et al. . Potential biomarkers associated with multiple sclerosis pathology. Int J Mol Sci. (2021) 22:10323. 10.3390/ijms221910323</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms221910323</ArticleId><ArticleId IdType="pmc">PMC8508638</ArticleId><ArticleId IdType="pubmed">34638664</ArticleId></ArticleIdList></Reference><Reference><Citation>Guzman-Martinez L, Maccioni RB, Andrade V, Navarrete LP, Pastor MG, Ramos-Escobar N. Neuroinflammation as a common feature of neurodegenerative disorders. Front Pharmacol. (2019) 10:1008. 10.3389/fphar.2019.01008</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2019.01008</ArticleId><ArticleId IdType="pmc">PMC6751310</ArticleId><ArticleId IdType="pubmed">31572186</ArticleId></ArticleIdList></Reference><Reference><Citation>Tracey KJ. The inflammatory reflex. Nature. (2002) 420:853&#x2013;9. 10.1038/nature01321</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature01321</ArticleId><ArticleId IdType="pubmed">12490958</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J, Song Y, Chen Z, Leng SX. Connection between systemic inflammation and neuroinflammation underlies neuroprotective mechanism of several phytochemicals in neurodegenerative diseases. Oxid Med Cell Longev. (2018) 2018:1972714. 10.1155/2018/1972714</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2018/1972714</ArticleId><ArticleId IdType="pmc">PMC6196798</ArticleId><ArticleId IdType="pubmed">30402203</ArticleId></ArticleIdList></Reference><Reference><Citation>Olofsson PS, Rosas-Ballina M, Levine YA, Tracey KJ. Rethinking inflammation: neural circuits in the regulation of immunity. Immunol Rev. (2012) 248:188&#x2013;204. 10.1111/j.1600-065X.2012.01138.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-065X.2012.01138.x</ArticleId><ArticleId IdType="pmc">PMC4536565</ArticleId><ArticleId IdType="pubmed">22725962</ArticleId></ArticleIdList></Reference><Reference><Citation>Watkins LR, Maier SF. Implications of immune-to-brain communication for sickness and pain. Proc Natl Acad Sci USA. (1999) 96:7710&#x2013;3. 10.1073/pnas.96.14.7710</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.96.14.7710</ArticleId><ArticleId IdType="pmc">PMC33606</ArticleId><ArticleId IdType="pubmed">10393885</ArticleId></ArticleIdList></Reference><Reference><Citation>Haruwaka K, Ikegami A, Tachibana Y, Ohno N, Konishi H, Hashimoto A, et al. . Dual microglia effects on blood brain barrier permeability induced by systemic inflammation. Nat Commun. (2019) 10:5816. 10.1038/s41467-019-13812-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-019-13812-z</ArticleId><ArticleId IdType="pmc">PMC6925219</ArticleId><ArticleId IdType="pubmed">31862977</ArticleId></ArticleIdList></Reference><Reference><Citation>Bested AC, Saunders PR, Logan AC. Chronic fatigue syndrome: neurological findings may be related to blood&#x2013;brain barrier permeability. Med Hypotheses. (2001) 57:231&#x2013;7. 10.1054/mehy.2001.1306</Citation><ArticleIdList><ArticleId IdType="doi">10.1054/mehy.2001.1306</ArticleId><ArticleId IdType="pubmed">11461179</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson C. Health Rising. (2018). Available online at: www.healthrising.org (accessed February, 2022).</Citation></Reference><Reference><Citation>Pereira G, Gillies H, Chanda S, Corbett M, Vernon SD, Milani T, et al. . Acute corticotropin-releasing factor receptor type 2 agonism results in sustained symptom improvement in myalgic encephalomyelitis/chronic fatigue syndrome. Front Syst Neurosci. (2021) 15:698240. 10.3389/fnsys.2021.698240</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnsys.2021.698240</ArticleId><ArticleId IdType="pmc">PMC8441022</ArticleId><ArticleId IdType="pubmed">34539356</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan J, Ma N, Zhong J, Yu B, Wan J, Zhang W. Age-associated changes in microglia and astrocytes ameliorate blood-brain barrier dysfunction. Mol Ther Nucleic Acids. (2021) 26:970&#x2013;86. 10.1016/j.omtn.2021.08.030</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.omtn.2021.08.030</ArticleId><ArticleId IdType="pmc">PMC8561003</ArticleId><ArticleId IdType="pubmed">34760339</ArticleId></ArticleIdList></Reference><Reference><Citation>Lull ME, Block ML. Microglial activation and chronic neurodegeneration. Neurotherapeutics. (2010) 7:354&#x2013;65. 10.1016/j.nurt.2010.05.014</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nurt.2010.05.014</ArticleId><ArticleId IdType="pmc">PMC2951017</ArticleId><ArticleId IdType="pubmed">20880500</ArticleId></ArticleIdList></Reference><Reference><Citation>Ronaldson PT, Davis TP. Regulation of blood-brain barrier integrity by microglia in health and disease: a therapeutic opportunity. J Cereb Blood Flow Metab. (2020) 40:S6&#x2013;24. 10.1177/0271678X20951995</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0271678X20951995</ArticleId><ArticleId IdType="pmc">PMC7687032</ArticleId><ArticleId IdType="pubmed">32928017</ArticleId></ArticleIdList></Reference><Reference><Citation>Rasa S, Nora-Krukle Z, Henning N, Eliassen E, Shikova E, Harrer T, et al. . Chronic viral infections in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). J Transl Med. (2018) 16:268. 10.1186/s12967-018-1644-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-018-1644-y</ArticleId><ArticleId IdType="pmc">PMC6167797</ArticleId><ArticleId IdType="pubmed">30285773</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamimura D, Ohki T, Arima Y, Ota M, Murakami M. Gateway reflex: local neuroimmune interactions that regulate blood vessels. Neurochem Int. (2019) 130:104303. 10.1016/j.neuint.2018.09.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuint.2018.09.011</ArticleId><ArticleId IdType="pubmed">30273641</ArticleId></ArticleIdList></Reference><Reference><Citation>Sabharwal L, Kamimura D, Meng J, Bando H, Ogura H, Nakayama C, et al. . The Gateway Reflex, which is mediated by the inflammation amplifier, directs pathogenic immune cells into the CNS. J Biochem. (2014) 156:299&#x2013;304. 10.1093/jb/mvu057</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jb/mvu057</ArticleId><ArticleId IdType="pubmed">25286911</ArticleId></ArticleIdList></Reference><Reference><Citation>Gate D, Tapp E, Leventhal O, Shahid M, Nonninger TJ, Yang AC, et al. . CD4(+) T cells contribute to neurodegeneration in Lewy body dementia. Science. (2021) 374:868&#x2013;74. 10.1126/science.abf7266</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abf7266</ArticleId><ArticleId IdType="pmc">PMC9122025</ArticleId><ArticleId IdType="pubmed">34648304</ArticleId></ArticleIdList></Reference><Reference><Citation>Sampson TR, Debelius JW, Thron T, Janssen S, Shastri GG, Ilhan ZE, et al. . Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson's disease. Cell. (2016) 167:1469&#x2013;80.e12. 10.1016/j.cell.2016.11.018</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2016.11.018</ArticleId><ArticleId IdType="pmc">PMC5718049</ArticleId><ArticleId IdType="pubmed">27912057</ArticleId></ArticleIdList></Reference><Reference><Citation>Schroeder BO, Backhed F. Signals from the gut microbiota to distant organs in physiology and disease. Nat Med. (2016) 22:1079&#x2013;89. 10.1038/nm.4185</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.4185</ArticleId><ArticleId IdType="pubmed">27711063</ArticleId></ArticleIdList></Reference><Reference><Citation>Selkrig J, Wong P, Zhang X, Pettersson S. Metabolic tinkering by the gut microbiome: implications for brain development and function. Gut Microbes. (2014) 5:369&#x2013;80. 10.4161/gmic.28681</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/gmic.28681</ArticleId><ArticleId IdType="pmc">PMC4153776</ArticleId><ArticleId IdType="pubmed">24685620</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xf6;hle L, Mattei D, Heimesaat MM, Bereswill S, Fischer A, Alutis M, et al. . Ly6C(hi) monocytes provide a link between antibiotic-induced changes in gut microbiota and adult hippocampal neurogenesis. Cell Rep. (2016) 15:1945&#x2013;56. 10.1016/j.celrep.2016.04.074</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2016.04.074</ArticleId><ArticleId IdType="pubmed">27210745</ArticleId></ArticleIdList></Reference><Reference><Citation>Braak H, Rub U, Gai WP, Del Tredici K. Idiopathic Parkinson's disease: possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen. J Neural Transm. (2003) 110:517&#x2013;36. 10.1007/s00702-002-0808-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00702-002-0808-2</ArticleId><ArticleId IdType="pubmed">12721813</ArticleId></ArticleIdList></Reference><Reference><Citation>Shannon KM, Keshavarzian A, Dodiya HB, Jakate S, Kordower JH. Is alpha-synuclein in the colon a biomarker for premotor Parkinson's Disease? Evidence from 3 cases. Mov Disord. (2012) 27:716&#x2013;9. 10.1002/mds.25020</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mds.25020</ArticleId><ArticleId IdType="pubmed">22550057</ArticleId></ArticleIdList></Reference><Reference><Citation>Thau L, Gandhi J, Sharma S. Physiology, Cortisol. Treasure Island, FL: StatPearls; (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">30855827</ArticleId></ArticleIdList></Reference><Reference><Citation>Morris G, Anderson G, Maes M. Hypothalamic-pituitary-adrenal hypofunction in myalgic encephalomyelitis (ME)/chronic fatigue syndrome (CFS) as a consequence of activated immune-inflammatory and oxidative and nitrosative pathways. Mol Neurobiol. (2017) 54:6806&#x2013;19. 10.1007/s12035-016-0170-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-016-0170-2</ArticleId><ArticleId IdType="pubmed">27766535</ArticleId></ArticleIdList></Reference><Reference><Citation>Hannibal KE, Bishop MD. Chronic stress, cortisol dysfunction, and pain: a psychoneuroendocrine rationale for stress management in pain rehabilitation. Phys Ther. (2014) 94:1816&#x2013;25. 10.2522/ptj.20130597</Citation><ArticleIdList><ArticleId IdType="doi">10.2522/ptj.20130597</ArticleId><ArticleId IdType="pmc">PMC4263906</ArticleId><ArticleId IdType="pubmed">25035267</ArticleId></ArticleIdList></Reference><Reference><Citation>Straub RH, Cutolo M. Glucocorticoids and chronic inflammation. Rheumatology. (2016) 55(suppl. 2):ii6&#x2013;14. 10.1093/rheumatology/kew348</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/kew348</ArticleId><ArticleId IdType="pubmed">27856655</ArticleId></ArticleIdList></Reference><Reference><Citation>Demitrack MA, Dale JK, Straus SE, Laue L, Listwak SJ, Kruesi MJ, et al. . Evidence for impaired activation of the hypothalamic-pituitary-adrenal axis in patients with chronic fatigue syndrome. J Clin Endocrinol Metab. (1991) 73:1224&#x2013;34. 10.1210/jcem-73-6-1224</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/jcem-73-6-1224</ArticleId><ArticleId IdType="pubmed">1659582</ArticleId></ArticleIdList></Reference><Reference><Citation>Misiak B, Loniewski I, Marlicz W, Frydecka D, Szulc A, Rudzki L, et al. . The HPA axis dysregulation in severe mental illness: can we shift the blame to gut microbiota? Prog Neuropsychopharmacol Biol Psychiatry. (2020) 102:109951. 10.1016/j.pnpbp.2020.109951</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pnpbp.2020.109951</ArticleId><ArticleId IdType="pubmed">32335265</ArticleId></ArticleIdList></Reference><Reference><Citation>Segura-Aguilar J, Huenchuguala S. Aminochrome induces irreversible mitochondrial dysfunction by inducing autophagy dysfunction in Parkinson's disease. Front Neurosci. (2018) 12:106. 10.3389/fnins.2018.00106</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2018.00106</ArticleId><ArticleId IdType="pmc">PMC5859232</ArticleId><ArticleId IdType="pubmed">29593482</ArticleId></ArticleIdList></Reference><Reference><Citation>Dinan TG. Serotonin and the regulation of hypothalamic-pituitary-adrenal axis function. Life Sci. (1996) 58:1683&#x2013;94. 10.1016/0024-3205(96)00066-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0024-3205(96)00066-5</ArticleId><ArticleId IdType="pubmed">8637392</ArticleId></ArticleIdList></Reference><Reference><Citation>Volpi-Abadie J, Kaye AM, Kaye AD. Serotonin syndrome. Ochsner J. (2013) 13:533&#x2013;40. 10.1007/978-1-4614-8948-1_49</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-4614-8948-1_49</ArticleId><ArticleId IdType="pmc">PMC3865832</ArticleId><ArticleId IdType="pubmed">24358002</ArticleId></ArticleIdList></Reference><Reference><Citation>Fatokun AA, Hunt NH, Ball HJ. Indoleamine 2,3-dioxygenase 2 (IDO2) and the kynurenine pathway: characteristics and potential roles in health and disease. Amino Acids. (2013) 45:1319&#x2013;29. 10.1007/s00726-013-1602-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00726-013-1602-1</ArticleId><ArticleId IdType="pubmed">24105077</ArticleId></ArticleIdList></Reference><Reference><Citation>Kashi AA, Davis RW, Phair RD. The IDO metabolic trap hypothesis for the etiology of ME/CFS. Diagnostics. (2019) 9:82. 10.3390/diagnostics9030082</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/diagnostics9030082</ArticleId><ArticleId IdType="pmc">PMC6787624</ArticleId><ArticleId IdType="pubmed">31357483</ArticleId></ArticleIdList></Reference><Reference><Citation>Badawy AA, Morgan CJ, Llewelyn MB, Albuquerque SR, Farmer A. Heterogeneity of serum tryptophan concentration and availability to the brain in patients with the chronic fatigue syndrome. J Psychopharmacol. (2005) 19:385&#x2013;91. 10.1177/0269881105053293</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0269881105053293</ArticleId><ArticleId IdType="pubmed">15982993</ArticleId></ArticleIdList></Reference><Reference><Citation>Kreisl WC, Kim MJ, Coughlin JM, Henter ID, Owen DR, Innis RB. PET imaging of neuroinflammation in neurological disorders. Lancet Neurol. (2020) 19:940&#x2013;50. 10.1016/S1474-4422(20)30346-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(20)30346-X</ArticleId><ArticleId IdType="pmc">PMC7912433</ArticleId><ArticleId IdType="pubmed">33098803</ArticleId></ArticleIdList></Reference><Reference><Citation>Krekorian M, Fruhwirth GO, Srinivas M, Figdor CG, Heskamp S, Witney TH, et al. . Imaging of T-cells and their responses during anti-cancer immunotherapy. Theranostics. (2019) 9:7924&#x2013;47. 10.7150/thno.37924</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/thno.37924</ArticleId><ArticleId IdType="pmc">PMC6814447</ArticleId><ArticleId IdType="pubmed">31656546</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei W, Jiang D, Ehlerding EB, Luo Q, Cai W. Noninvasive PET Imaging of T cells. Trends Cancer. (2018) 4:359&#x2013;73. 10.1016/j.trecan.2018.03.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.trecan.2018.03.009</ArticleId><ArticleId IdType="pmc">PMC6034116</ArticleId><ArticleId IdType="pubmed">29709260</ArticleId></ArticleIdList></Reference><Reference><Citation>Taheri S, Gasparovic C, Shah NJ, Rosenberg GA. Quantitative measurement of blood-brain barrier permeability in human using dynamic contrast-enhanced MRI with fast T1 mapping. Magn Reson Med. (2011) 65:1036&#x2013;42. 10.1002/mrm.22686</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mrm.22686</ArticleId><ArticleId IdType="pmc">PMC4950947</ArticleId><ArticleId IdType="pubmed">21413067</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin Z, Jiang D, Liu D, Li Y, Uh J, Hou X, et al. . Noncontrast assessment of blood-brain barrier permeability to water: shorter acquisition, test-retest reproducibility, and comparison with contrast-based method. Magn Reson Med. (2021) 86:143&#x2013;56. 10.1002/mrm.28687</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mrm.28687</ArticleId><ArticleId IdType="pmc">PMC8466682</ArticleId><ArticleId IdType="pubmed">33559214</ArticleId></ArticleIdList></Reference><Reference><Citation>Groff D, Sun A, Ssentongo AE, Ba DM, Parsons N, Poudel GR, et al. . Short-term and long-term rates of postacute sequelae of SARS-CoV-2 Infection: a systematic review. JAMA Netw Open. (2021) 4:e2128568. 10.1001/jamanetworkopen.2021.28568</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.28568</ArticleId><ArticleId IdType="pmc">PMC8515212</ArticleId><ArticleId IdType="pubmed">34643720</ArticleId></ArticleIdList></Reference><Reference><Citation>ANZMES. 
ANZMES Preliminary survey findings. (2021). Available online at: https://anzmes.org.nz/ (accessed February, 2022).</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>